Description: Liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 70 cases/70 cores, replacing BC03116

Description: Hepatitis B liver cancer and liver tissue array, including pathology grade, TNM, clinical stage and HBV data, 99 cases/140 cores

Description: Different stages of liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

Description: Liver cancer and normal adjacent liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores (1.5mm), replacing LV801a

Description: Pooled Human Liver Microsomes provide a fully characterized, relevant, reliable and reproducible in vitro tool. Pooled of 50 donors give an economic way of deriving an accurate population representation and may be used to describe the metabolic profile of a drug or drug candidate in high-throughput assays as well as the following other uses: Conduct studies of metabolic stability (% of original drug remaining over time) Identify which cytochrome P450 (CYP) enzymes oxidize a drug candidate and which UDP-glucuronosyltransferase (UGT) enzymes are responsible for glucuronidation Identify, quantify and characterize drug metabolites Describe a drug’s metabolic pathways Identify inhibition of cytochrome P450 (CYP) enzymes

Description: Pooled Human Liver Microsomes provide a fully characterized, relevant, reliable and reproducible in vitro tool. Pooled of 50 donors give an economic way of deriving an accurate population representation and may be used to describe the metabolic profile of a drug or drug candidate in high-throughput assays as well as the following other uses: Conduct studies of metabolic stability (% of original drug remaining over time) Identify which cytochrome P450 (CYP) enzymes oxidize a drug candidate and which UDP-glucuronosyltransferase (UGT) enzymes are responsible for glucuronidation Identify, quantify and characterize drug metabolites Describe a drug’s metabolic pathways Identify inhibition of cytochrome P450 (CYP) enzymes

Description: Pooled Human Liver Microsomes provide a fully characterized, relevant, reliable and reproducible in vitro tool. Pooled of 200 donors give an accurate population representation and may be used to describe the metabolic profile of a drug or drug candidate in high-throughput assays as well as the following other uses: Conduct studies of metabolic stability (% of original drug remaining over time) Identify which cytochrome P450 (CYP) enzymes oxidize a drug candidate and which UDP-glucuronosyltransferase (UGT) enzymes are responsible for glucuronidation Identify, quantify and characterize drug metabolites Describe a drug’s metabolic pathways Identify inhibition of cytochrome P450 (CYP) enzymes

Description: CheKine™ Micro Water and Soil Nitrite Content Assay Kit provides a simple, convenient and rapid method for the determination of nitrite content, which is suitable for water and soil samples. The detection principle is that under acidic conditions, nitrite reacts with p-aminobenzene sulfonic acid to form diazo compounds, and then reacts with Nmuri 1-naphthyl ethylenediamine to form purplish red azo compounds with a characteristic absorption peak at 540 nm.

Description: Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a

Description: Mouse Liver Microvascular Endothelial cells (mLivMECs) are isolated from livers of 3-week old male C57BL/6 mice and GFP expressing mLivMECs-GFP were selected from puromycin resistant cells after transfected with lentiviral expressing GFP. Cells are shipped in a frozen vial (provided @ passage 3, with 5 x 105 cells/vial). mLivMECs-GFP are cultured with specially formulated Endothelial Growth Medium. Since the cells have limited proliferation capacity (cells may be expanded for a maximum of 2-3 passages) in vitro, long term culture of mLivMECs is not recommended, evencultured following the detailed protocol described below).

Description: Liver cancer (stage III) and liver tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 34 cases/68 cores